Impact of compliance to oral cysteamine treatment on the costs of Kidney failure in patients with nephropathic cystinosis in the United Kingdom.

Lashilola, Seun; Xu, Weiwei; Azimpour, Khashayar; McCarthy, Michael; Carlot, Sara; Game, David; van der Voort, Judith

Lashilola, Seun; Xu, Weiwei; Azimpour, Khashayar; McCarthy, Michael; Carlot, Sara; Game, David; van der Voort, Judith.

Afiliación

Lashilola S; Real World Insights, IQVIA, London, UK.
Xu W; Real World Insights, IQVIA, Amsterdam, the Netherlands. Weiwei.xu@iqvia.com.
Azimpour K; Global Health Economics and Outcome Research, Chiesi, Boston, United States.
McCarthy M; Health Economics and Outcomes Research, MAP Patient Access, Cambridge, UK.
Carlot S; Global Rare Diseases Business Unit, Chiesi Farmaceutici S.p.A, Parma, Italy.
Game D; Department of Nephrology, Guy's Hospital, London, UK.
van der Voort J; Department of Paediatric Nephrology, University Hospital of Wales, Cardiff, Wales.

BMC Nephrol ; 24(1): 351, 2023 11 29.

Article en En | MEDLINE | ID: mdl-38031005

Asunto(s)

Cistinosis; Síndrome de Fanconi; Insuficiencia Renal; Humanos; Cistinosis/complicaciones; Cistinosis/tratamiento farmacológico; Cistinosis/metabolismo; Cisteamina/uso terapéutico; Cistina/metabolismo; Diálisis Renal; Cooperación del Paciente; Reino Unido

Palabras clave

Adherence; Delayed-release Cysteamine Bitartrate; Kidney Failure; Nephropathic cystinosis; Treatment compliance; United Kingdom

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cistinosis / Insuficiencia Renal / Síndrome de Fanconi Límite: Humans País/Región como asunto: Europa Idioma: En Revista: BMC Nephrol Asunto de la revista: NEFROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google